Researchers & Healthcare Professionals

Myeloma - The Latest on Research and Treatment from the American Society of Hematology (ASH®) Annual Meeting

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: January 29, 2013
CE Credit Available Until: October 23, 2014
Location: Virtual Lecture
Target Audience: Oncology nurses and social workers involved in the treatment of myeloma
Read: Myeloma News | Program Slides | Transcript
Listen: Presentation | Q&A Session
Access: Virtual Lecture

Activity Purpose

To educate oncology nurses and social workers about the latest research and treatment for myeloma

Educational Objectives

At the conclusion of this program, participants should be able to:

  • Explain updates about current and emerging myeloma treatment options
  • Review updates in myeloma maintenance therapy
  • Communicate the role of clinical trials in the advancement of myeloma treatment to patients
  • Describe advances in myeloma treatment side effects management


Kenneth C. Anderson, MD
Kraft Family Professor of Medicine
Department of Medicine
Harvard Medical School
Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

Sponsors and Supporters

This program is sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation, Millennium: The Takeda Oncology Company, and Onyx Pharmaceuticals, Inc.

This program is not sponsored, sanctioned by, or part of the 54th Annual Meeting of the American Society of Hematology (ASH®)

last updated on Thursday, June 27, 2013